Lauran Neergaard

AP Medical Writer
Latest in Home
Astemo
HEV Motor Production Increasing in Kentucky
September 1, 2026
599
New Metal Foam Could Make Car Crashes Safer
September 4, 2026
A pint of Guinness beer is poured on St. Patrick's Day on March 17, 2023, in Bellows Falls, Vt.
Police Looking for $155K Worth of Stolen Guinness Stout
September 4, 2026
The logo of Japanese motor-maker Nidec Corp., is seen in Kyoto, Japan, on May 15, 2026.
Motor Maker Nidec Finds Hundreds of Cases of Quality Control Misconduct
September 4, 2026
Related Stories
Takata has agreed to recall another 35 million to 40 million air bag inflators, a stunning increase that will more than double what already is the largest automotive recall in American history. (AP Photo/Evan Vucci)
Safety
US Adds Up To 40M Airbags To Takata Recall
(AP Photo)
Operations
Johnson & Johnson Hit With Another Multi-Million Dollar Verdict Over Talcum Powder
Mnet 123522 Aptopix Severe Weathe Parr
Chemical Processing
The Culprit Behind Houston’s Flooding Problems
Joyce Ertel Hulbert, owner of a 2015 Volkswagen Golf TDI, holds a sign while interviewed outside of the Phillip Burton Federal Building in San Francisco, Thursday, April 21. (AP Photo/Jeff Chiu)
Safety
Volkswagen To Take $18.2B Hit From Emissions Scandal
More from Lauran Neergaard
This Wednesday, Dec. 23, 2020 file photo shows a vial of the Moderna COVID-19 vaccine in the first round of staff vaccinations at a hospital in Denver. On Thursday, Oct. 14, 2021, U.S. health advisers said that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
Operations
FDA Panel Endorses Lower-Dose Moderna COVID Shot for Booster
But there's no evidence that it's time to open booster doses of either the Moderna or Pfizer vaccine to everybody, the panel stressed.
October 15, 2021
In this May 19, 2021, file photo, a licensed practical nurse draws a Moderna COVID-19 vaccine into a syringe at a mass vaccination clinic at Gillette Stadium in Foxborough, Mass. Starting Thursday, Oct. 14, 2021, the Food and Drug Administration convenes its independent advisers for the first stage in the process of deciding whether extra shots of Moderna or Johnson & Johnson vaccines should be dispensed and, if so, who should get them and when.
Laws & Regulations
Next on FDA's Agenda: Booster Shots of Moderna, J&J Vaccines
The panel will also look into the safety and effectiveness of mixing-and-matching different brands of vaccine.
October 12, 2021
In this Jan. 8, 2021, file photo, a pharmacist prepares a syringe of the Pfizer vaccine for COVID-19, at Queen Anne Healthcare, a skilled nursing and rehabilitation facility in Seattle. The U.S. vaccination drive against COVID-19 stood on the verge of a major new phase as government advisers Thursday, Sept. 23, recommended booster doses of Pfizer's vaccine for millions of older or otherwise vulnerable Americans — despite doubts the extra shots will do much to slow the pandemic.
Safety
CDC Adds People with Risky Jobs to COVID Booster List
The booster plan marks an important shift in the nation's vaccination drive.
September 24, 2021
In this file photo, staff members administer the AstraZeneca vaccine at La Nuvola (The Cloud) convention center that was temporarily turned into a COVID-19 vaccination hub in Rome.
Safety
AstraZeneca: US Data Shows Vaccine Effective for All Adults
Concerns about blood clots in European countries have also been addressed.
March 22, 2021
This Sept. 2020 photo provided by Johnson & Johnson shows a clinician preparing to administer investigational Janssen COVID-19 vaccine.
Safety
J&J 1-Dose Shot Works, Less Effective Than Others
It appears to protect against COVID-19, but not as strongly as some two-shot rivals.
January 29, 2021
In this file photo, empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas in Las Vegas.
Supply Chain
Why it's Hard to Make Vaccines and Boost Supplies
"It's not like adding more water to the soup."
January 28, 2021
Catalina Gonzalez-Marques, an emergency medical physician, receives the Pfizer-BioNTech coronavirus vaccine.
Safety
Health Officials Track Safety as COVID-19 Vaccines Roll Out
Vaccine recipients are supposed to hang around after the injection in case signs of an allergy appear.
December 17, 2020
Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped at the Pfizer Global Supply Kalamazoo manufacturing plant in Portage, Mich., Sunday, Dec. 13, 2020.
Home
US Set for First COVID-19 Shots as Shipments Begin Arriving
Now the hurdle is to rapidly get vaccine into the arms of millions.
December 14, 2020
Blood samples from volunteers participating in the last-stage testing of the COVID-19 vaccine by Moderna and the National Institutes.
Home
Years of Research Laid Groundwork for Speedy COVID-19 Shots
More than a decade of behind-the-scenes work is credited for the success.
December 8, 2020
The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore.
Home
UK Authorizes Pfizer Coronavirus Vaccine for Emergency Use
The company's shot is the first to be backed up by rigorous scientific review.
December 2, 2020
Nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine.
Home
Moderna Asks US, European Regulators to OK its Vaccine
Study results suggest the vaccine is more than 94% effective.
November 30, 2020
Pedestrians walk past Pfizer world headquarters in New York.
Home
Pfizer Seeking Emergency Use of its COVID-19 Vaccine in US
Limited first shots could start as early as next month.
November 20, 2020
In this July 27, 2020, file photo, nurse Kathe Olmstead prepares a shot that is part of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., in Binghamton, N.Y. Moderna said Monday, Nov. 16, 2020, its COVID-19 shot provides strong protection against the coronavirus that's surging in the U.S. and around the world.
Technology
2nd Vaccine Shows Overwhelming Success in US Tests
Moderna has added a second dash of hope in the global race for a shot.
November 16, 2020
I Stock 1205972800
Home
Testing Timeline: What’s Ahead for COVID-19 Vaccines
Here's how the different shots will make it to market.
November 10, 2020
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
Home
US Experts Vow 'No Cutting Corners' as Vaccine Tests Expand
Hopes are high that answers about at least one of several candidates could come by year's end.
September 24, 2020